Risperdal Verdicts: The Drug Worth Two Fortunes

risperdal verdicts

Risperdal verdicts and lawsuit settlements have been piling up since 2012 after consumers learned that Johnson & Johnson had been marketing the drug outside of its approved use.

Prescription drugs help millions of people every day. But they come with costly side effects. When manufacturers don’t disclose the worst side effects—or illegally market a drug to broaden the base of buyers—consumers get hurt. Sometimes those injuries are irreparable.

Take a look at the infographic for the straight facts and numbers, including data straight from Johnson & Johnson’s financial reports, about the fortune Johnson & Johnson has lost—and made—on Americans’ mental health struggles.

From the infographic:

Risperdal, a drug first made to help patients fight schizophrenia, has made a fortune around the globe. But lawsuits claim that Johnson & Johnson’s drug arm called Janssen Pharmaceutica illegally marketed the drug for underage patients with a wide spectrum of illnesses for which it had not been properly tested. Several Risperdal verdicts have been ruled in favor of plaintiffs.

Here’s the fortune Risperdal has made, and the fortune it has lost.

Total Risperdal Verdicts Against Johnson & Johnson

The following data represents cases claiming injuries related to Risperdal. Some of these cases are brought by states and claim false, misrepresentative, or other illegal marketing tactics were used.

  • $158,000,000
    • Johnson & Johnson lost a civil lawsuit to the state of Texas in January 2012 for “improper marketing.”
  • $181,000,000
    • Johnson & Johnson settled with 36 states at once in cases against its promotional and marketing practices.
  • $2,200,000,000
    • In 2013, the Justice Department sued Johnson & Johnson for marketing Risperdal to doctors for children and for the elderly, which it did not have clearance to do.
  • $5,900,000
    • The state of Montana sued Johnson & Johnson for false claims and won a verdict in March 2014.
  • $2,500,000
    • In 2015, the family of an autistic boy won a lawsuit after their son developed size 46 DD breasts while taking Risperdal.
  • $7,500,000
    • An Arkansas jury originally granted a family $1.2 billion. The Arkansas Supreme Court reduced the sentence to $7.5 million in May 2015.
  • $1,750,000
    • A Philadelphia boy took Risperdal from 2003 to 2008 for his autism spectrum disorder. He grew breasts and endured severe bullying. The jury decided in his favor in November 2015.
  • $124,000,000
    • The US Supreme Court reduced the sentence on a South Carolina civil suit from $327 million to $124 million in January 2016.
  • Total: $2,680,650,000
    • Johnson & Johnson has paid at least $2.68 billion to settle claims of false advertising and negligent behavior. And the lawsuits aren’t over yet.

Risperdal Annual Profits

Now that you have an idea about how lawsuits are shaping up against Risperdal between 2012 and 2016, let’s take a look at the available financial data provided in Johnson & Johnson’s Investor Report for each year between 2003 and 2014 to see why the company continues to manufacture a drug at the center of so much litigation.


If you or someone you loved has suffered severe side effects, including gynecomastia, due to Risperdal, you may qualify to file a Risperdal lawsuit.

Sources, accessed Feb 25 – 26, 2016:

  • http://scholar.aci.info/view/149cddfb6304e24013c/152375c142500010008
  • http://www.prnewswire.com/news-releases/175-million-jury-verdict-awarded-in-risperdal-antipsychotic-lawsuit-sheller-pc-plaintiff-alleged-drug-caused-female-like-breast-development-300176381.html
  • http://www.fiercepharma.com/story/jj-nears-75m-deal-risperdal-case-could-have-cost-12b/2015-05-19
  • http://blogs.wsj.com/pharmalot/2015/02/24/johnson-johnson-loses-trial-over-risperdal-and-male-breasts/
  • http://www.thenationaltriallawyers.org/2014/03/risperdal-lawsuit-montana-5-9-million-settlement/
  • http://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations
  • https://www.jnj.com/news/all/janssen-pharmaceuticals-inc-announces-risperdal-consumer-protection-settlement-with-36-states-and-the-district-of-columbia
  • http://www.reuters.com/article/us-johnsonandjohnson-idUSTRE80I1JF20120119
  • http://articles.philly.com/2012-09-01/business/33522312_1_risperdal-case-johnson-johnson-federal-investigation
  • http://www.ag.ny.gov/press-release/ag-schneiderman-settles-181-million-deceptive-marketing-case-janssen-pharmaceuticals
  • http://www.investor.jnj.com/gov/annualmeetingmaterials.cfm